Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1
Clinical trial NCT02707861 · COMPLETED
Trial details
- NCT number
- NCT02707861
- Sponsor
- TaiMed Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-11-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.